Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Mar;51(3):347–356. doi: 10.1038/bjc.1985.46

Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

S Aamdal, O Fodstad, J M Nesland, A Pihl
PMCID: PMC1976949  PMID: 3970811

Abstract

Human tumour lines established in athymic nude mice were grafted under the renal capsule of immunocompetent mice. Grafts from 27 human tumour lines comprising 9 malignant melanomas, 10 sarcomas, 2 colon carcinomas, 4 lung carcinomas and 2 mammary carcinomas, grew well under the renal capsule of the immunocompetent mice and retained morphological and functional characteristics of the parent tumours, as judged by light and electron microscopy and immunohistochemical examinations. Numerous mitoses were detected. Granulation tissue and necrosis were not predominant features. After Day 4, the grafts became infiltrated from the periphery by mouse inflammatory cells. The infiltration could be prevented by pretreatment of the animals with cyclophosphamide. Anti-human antibodies were detected after Day 3. Single cell suspensions from the subrenal grafts were able to form colonies in soft agar. and upon reimplantation in nude mice, subcutaneous tumours were formed showing that the grafted tumour tissue had also retained its malignant character. Altogether the results support the view that human tumour xenografts grow well under the renal capsule of immunocompetent mice and that the grafts retain important characteristics of the original tumour.

Full text

PDF
347

Images in this article

349Figure 1
on p.349
351Figure 3
on p.351
351Figure 4
on p.351
351Figure 5
on p.351
352Figure 6
on p.352
352Figure 7
on p.352
353Figure 8
on p.353

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aamdal S., Fodstad O., Pihl A. Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response. Int J Cancer. 1984 Nov 15;34(5):725–730. doi: 10.1002/ijc.2910340521. [DOI] [PubMed] [Google Scholar]
  2. Bellet R. E., Danna V., Mastrangelo M. J., Berd D. Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents. J Natl Cancer Inst. 1979 Nov;63(5):1185–1188. [PubMed] [Google Scholar]
  3. Bogden A. E., Haskell P. M., LePage D. J., Kelton D. E., Cobb W. R., Esber H. J. Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice. Exp Cell Biol. 1979;47(4):281–293. doi: 10.1159/000162947. [DOI] [PubMed] [Google Scholar]
  4. Cobb W. R., Bogden A. E., Reich S. D., Griffin T. W., Kelton D. E., LePage D. J. Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay. Cancer Treat Rep. 1983 Feb;67(2):173–178. [PubMed] [Google Scholar]
  5. Edelstein M. B., Fiebig H. H., Smink T., Van Putten L. M., Schuchhardt C. Comparison between macroscopic and microscopic evaluation of tumour responsiveness using the subrenal capsule assay. Eur J Cancer Clin Oncol. 1983 Jul;19(7):995–1009. doi: 10.1016/0277-5379(83)90070-6. [DOI] [PubMed] [Google Scholar]
  6. Fodstad O., Aass N., Pihl A. Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice. Br J Cancer Suppl. 1980 Apr;4:146–149. [PMC free article] [PubMed] [Google Scholar]
  7. Fodstad O., Olsnes S., Pihl A. Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice. Cancer Res. 1977 Dec;37(12):4559–4567. [PubMed] [Google Scholar]
  8. Giovanella B. C., Stehlin J. S., Jr, Shepard R. C., Williams L. J., Jr Correlation between response to chemotherapy of human tumors in patients and in nude mice. Cancer. 1983 Oct 1;52(7):1146–1152. doi: 10.1002/1097-0142(19831001)52:7<1146::aid-cncr2820520704>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  9. Giovanella B. C., Stehlin J. S., Williams L. J., Jr Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J Natl Cancer Inst. 1974 Mar;52(3):921–930. doi: 10.1093/jnci/52.3.921. [DOI] [PubMed] [Google Scholar]
  10. Giuliani F. C., Zirvi K. A., Kaplan N. O., Goldin A. Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin. Int J Cancer. 1981 Jan 15;27(1):5–13. doi: 10.1002/ijc.2910270103. [DOI] [PubMed] [Google Scholar]
  11. Godal A., Fodstad O., Pihl A. Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice. Int J Cancer. 1983 Oct 15;32(4):515–521. doi: 10.1002/ijc.2910320420. [DOI] [PubMed] [Google Scholar]
  12. Griffin T. W., Bogden A. E., Reich S. D., Antonelli D., Hunter R. E., Ward A., Yu D. T., Greene H. L., Costanza M. E. Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer. 1983 Dec 15;52(12):2185–2192. doi: 10.1002/1097-0142(19831215)52:12<2185::aid-cncr2820521202>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  13. Houghton J. A., Taylor D. M. Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer. 1978 Feb;37(2):199–212. doi: 10.1038/bjc.1978.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kopper L., Steel G. G. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res. 1975 Oct;35(10):2704–2713. [PubMed] [Google Scholar]
  15. McDowell E. M., Trump B. F. Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med. 1976 Aug;100(8):405–414. [PubMed] [Google Scholar]
  16. Meera Khan P. Enzyme electrophoresis on cellulose acetate gel: zymogram patterns in mgh-mouse and man--Chinese hamster somatic cell hybrids. Arch Biochem Biophys. 1971 Aug;145(2):470–483. doi: 10.1016/s0003-9861(71)80007-3. [DOI] [PubMed] [Google Scholar]
  17. Nowak K., Peckham M. J., Steel G. G. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer. 1978 Apr;37(4):576–584. doi: 10.1038/bjc.1978.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Osieka R., Houchens D. P., Goldin A., Johnson R. K. Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer. 1977 Nov;40(5 Suppl):2640–2650. doi: 10.1002/1097-0142(197711)40:5+<2640::aid-cncr2820400938>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  19. Ovejera A. A., Houchens D. P., Barker A. D. Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci. 1978 Jan-Feb;8(1):50–56. [PubMed] [Google Scholar]
  20. Povlsen C. O., Jacobsen G. K. Chemotherapy of a human malignant melanoma transplanted in the nude mouse. Cancer Res. 1975 Oct;35(10):2790–2796. [PubMed] [Google Scholar]
  21. Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011. [DOI] [PubMed] [Google Scholar]
  22. Tveit K. M., Fodstad O., Lotsberg J., Vaage S., Pihl A. Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters. Int J Cancer. 1982 May 15;29(5):533–538. doi: 10.1002/ijc.2910290508. [DOI] [PubMed] [Google Scholar]
  23. Venditti J. M. Preclinical drug development: rationale and methods. Semin Oncol. 1981 Dec;8(4):349–361. [PubMed] [Google Scholar]
  24. Watson R. D., Smith A. G., Levy J. G. The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma. Br J Cancer. 1975 Sep;32(3):300–309. doi: 10.1038/bjc.1975.228. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES